A cirrhosis cohort reported benzodiazepines or hypnotics alongside opioids without isolating their contribution to hospital outcomes.
The retrospective cohort included 217 hospitalized adults with cirrhosis, excluding selected surgical, procedural, and palliative-care admissions. Opioids were administered to 118 patients. Among opioid recipients, 28.8% also received benzodiazepines or hypnotic sleep aids.
Opioid recipients had longer hospital stays, including after adjustment for recorded factors. Intensive care transfers did not differ significantly, and no inpatient deaths occurred in the sample.
The benzodiazepine-or-hypnotic measure combined different medicines. The reported length-of-stay association concerned opioid exposure, not an independently established benzodiazepine effect. The small number of severe outcomes limited assessment of those endpoints.
For review of a cirrhosis admission, separate the exact sedative, timing, indication, liver disease severity, and clinical course. This study documents coadministration patterns in a selected setting. It cannot establish that the combination caused prolonged admission or that absence of observed deaths proves safety.
Original analysis of the supplied journal article, identified as PMC7043759.